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Background: Female sexual function (FSD) is a complex phenomenon. It integrates all body
systems and is influenced by a variety of factors. Contraceptives have shown to have variable
effects on FSD. In Kenya, the majority of women use hormonal contraception with high
rates of discontinuation of use, attributed to related side effects such as weight loss and loss
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Setting: The study was carried out at the Aga Khan University Hospital, Nairobi, at various
clinical sites.
Methods: A cross-sectional study was conducted. Consecutive sampling of women of
reproductive age using either hormonal or non-hormonal contraception was conducted. Two
questionnaires were completed after obtaining informed consent. Independent associations
of factors with the outcome variables were assessed using the chi-square test of association,
and variables with a p < 0.25 were used in the multivariate analysis. Factors associated with
FSD were determined using binary logistic regression.
Results: A total of 566 participants were included. The prevalence of FSD among those using
hormonal and those using non-hormonal contraception was 51.5% and 29.6%, respectively
(p < 0.0001). We found that the factors associated with FSD were presence of chronic illness and
use of chronic medication, being self-employed or unemployed, alcohol intake and history of
miscarriage(s).
Conclusion: There was a high prevalence of and a strong association between hormonal
contraception and FSD. More studies on this topic in different settings are recommended to
investigate the effect of each type of hormonal method on FSD.
Keywords: prevalence; female sexual dysfunction; contraception; hormonal; non-hormonal.

Introduction
Sexual function is an important component of sexual health that determines the general wellbeing of a person.1 Female sexual dysfunction (FSD), which is the decrease in sexual desire or
arousal, or the presence of dyspareunia and difficulty/inability to achieve orgasm, can cause
personal distress.1 Female sexual dysfunction is a common problem globally, and the factors
associated with it have been highlighted in the literature and broadly divided into five main
groups. These include biological factors such as hormonal status that can be influenced by the use
of hormonal contraception; demographic factors such as age and education levels; psychological
factors, including mental health conditions, such as anxiety and depression; sociocultural factors
such as religion and traditional customs; and finally the pathophysiological factors that are
complications associated with chronic conditions such as diabetes mellitus and rheumatoid
arthritis. These factors have been illustrated in the biopsychosocial model of FSD. All the abovedescribed factors are far from having a predictable effect on sexual function and have been shown
to have variable effects in different studies. They are defined as the association of demographic
factors such as increasing age, increasing parity and lower levels of education, which have been
shown to have a significant negative effect on sexual function.2 Other studies draw completely
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opposite conclusions, so no current consensus exists on
predictability of the effect of most of the above factors.
The current female sexual response model is a circular one,
which was elaborated by Basson in the year 2000 and has
evolved from two previous linear models: the first described
by Masters and Johnson in 1966 and the other that had
eliminated one of the previously described stages by Kaplan
et al. in 1979. The non-linear model acknowledges and
addresses the effect of the other factors, such as relationship
status and emotional receptivity, on the outcome of sexual
response and is, therefore, generally more acceptable.3
Contraception is one such factor, the biochemical effects of
which have a clear association with sexual function, such
as reduced vaginal lubrication, leading to dyspareunia. The
current contraceptive prevalence rate in Kenya is 58%, with
the majority of women using hormonal methods. Significant
proportions (31%) of the users discontinue use within 1 year
of starting because of side effects of the contraceptive
methods.4
Sexuality is a taboo subject in many societies, and women and
physicians do not routinely discuss effects of contraception
on sexual health. It was therefore important to examine the
effect of hormonal contraception on FSD to have contextually
relevant information for women seeking to be on or already
on contraception because a high number of women are
already using hormonal contraception methods.
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Women attending the above-named clinics, who were in the
specified age category, were approached by the triage nurse.
The eligibility of the subjects was confirmed using a set of
three questions about their age, whether they spoke English
and if they were using any contraceptive. The eligible women
who agreed to participate in the study were given two
questionnaires: the demographic questionnaire and the
Female Sexual Function Index (FSFI) to be filled in a separate
private room. The participants were asked to drop them in a
sealed box at the triage station after they had filled them.

Inclusion criteria
Women aged between 18 and 49 years who attended the
AKUHN clinics, and who could read and write in English
were included in the study. This was mainly because the
study questionnaire had not been validated in Kiswahili or
any other local language from our set-up. The participants
also had to be sexually active and in a heterosexual
relationship for the past 4 weeks prior to participating in the
study. The participants had to be using any type of
contraception, particularly only one type of contraception for
the past 6 months.

Exclusion criteria

This study aimed to compare the prevalence of sexual
dysfunction in women attending the Aga Khan University
Hospital, Nairobi (AKUHN) clinics using hormonal
contraception to those using non-hormonal contraception,
to determine and examine the other factors associated
with FSD.

Women who had a known psychiatric illness and history of
sexual dysfunction were excluded from the study. Also,
women who had undergone pelvic floor surgery, had chronic
pelvic pain syndromes or a history of any gynaecological
malignancy were excluded, as these conditions are known to
have a negative influence on sexual function. Women who
had switched from one type of contraception to another in
the past 6 months were also excluded as this is the duration
beyond which, according to the DSM-5, a diagnosis of sexual
dysfunction can be made from persistence of particular
symptoms.

Research methods and design

Data collection

Study design

Sample size calculation

This was an analytical, cross-sectional survey.

The formula used for sample size determination was that for
comparison of proportions between two groups:

Study setting
The study was carried out at the Aga Khan University
Hospital, which is a tertiary care referral hospital that
generally serves a wide variety of individuals with different
social and demographic characteristics. The clinics identified
to be used for the study were the family planning clinic,
family medicine clinic and gynaecology outpatient clinic.

Study population and sampling strategy
The cohort studied were women of reproductive age
(18–49 years) who were using any form of contraception. To
be recruited, participants had to be aged 18 years or above to
give informed consent. Consecutive sampling technique was
used to recruit participants from the clinics until the required
sample size was achieved.
http://www.phcfm.org

n=

[ p1 (1 − p1 ) + p2 (1 − p2 )]
× cp.power
( p1 − p2 ) 2

[Eqn 1]

where n is the sample size, P1 is the prevalence of sexual
dysfunction in proportion one and P2 is the prevalence of
sexual dysfunction in proportion two. The power of the
study was set at 80%. The value of α was set at 0.05 (95%).
The Cp.power was 7.9. Using the 2017 study by Oindi et al.
(an unpublished study conducted at AKUHN), the prevalence
they obtained from their study was used for calculating
sample size, where P1 was the prevalence of sexual
dysfunction in the group of women in the study who were
using non-hormonal contraception. We aimed to detect at
least a 10% difference (P1 = 26.9%)5 in proportion with FSD in
this group. A 10% difference in prevalence of FSD between
the two groups was thought to be clinically significant.
Open Access
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P2 was the prevalence of sexual dysfunction in the cohort
of women attending AKUHN clinics using hormonal
contraception, reported as 36.9%. The calculations using the
above formula for comparison of proportions gave a sample
size of 283 women in each arm. This was then multiplied by
two to get a total sample size of 566 women.
A two-part questionnaire was used to collect the data. The
first part was about sociodemographic information and
the second part entailed sexual function in women.
The sociodemographic questionnaire collected information
on the age of the subject; the age of the partner; parity; race;
marital status; religion; alcohol intake; smoking status;
employment status; presence of chronic illnesses, for example,
hypertension, diabetes mellitus and rheumatoid arthritis; if
they were currently on any medication for the aforementioned
conditions; and the type of contraception that was currently
being used (hormonal or non-hormonal).
The FSFI questionnaire was used to collect information on the
outcome variable. This is a 19-item questionnaire that was
developed as a brief, multidimensional self-report tool to
assess the important aspects of sexual function in women. It is
a generally well-accepted tool and has been used in several
studies across the world. It is easier to administer than most in
terms of simplicity. It has also been tested for validity and
inter-rater cross-reliability. The features examined in the
desire domain include frequency of desiring intercourse,
level of desire of intercourse, satisfaction and confidence
with performing intercourse. The arousal domain included
frequency of successful intercourse and difficulty in getting
aroused for intercourse. The lubrication domain included
frequency of attaining and difficulty in maintaining
lubrication. The pain domain assesses frequency of pain
during vaginal penetration, frequency following vaginal
penetration and level of pain during and following vaginal
penetration. The satisfaction domain mainly assessed factors
like satisfaction with the amount of closeness with the sexual
partner, satisfaction with the sexual relationship and, in
general, satisfaction with one’s sexual life.6

Data analysis
At the end of the day, the questionnaires were checked
for completion by the triage nurse who then filed the
questionnaires and stored them in a locked cupboard for
collection. The data from the forms were entered into a
Microsoft Excel sheet in a password-protected computer and
later analysed using SPSS (Statistical Package for the Social
Sciences) version 22.
Continuous variables were summarised using means or
median with their corresponding measures of variability
(standard deviation [s.d.] or interquartile range [IQR]), while
categorical data were summarised using frequency counts
with corresponding percentages. Prevalence of FSD was
calculated as a proportion of the women with FSD in the
population of all women interviewed. This was stratified by
http://www.phcfm.org
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the type of contraceptive (hormonal and non-hormonal)
used, and the two proportions were compared using two
sample tests of independent populations.
The FSFI scores were calculated using the responses to the
questions from each of the domains. All questions had a
score range of 1 to 5, with two questions for desire domain;
four questions each for arousal and vaginal lubrication,
orgasm; and three questions each for pain and sexual
satisfaction. The total score was calculated by adding the
scores in a particular domain, and then multiplying it by a
set coefficient for each domain. The set coefficients were
0.3 for sexual arousal and vaginal lubrication, 0.6 for desire
and 0.4 for orgasm, sexual pain and sexual satisfaction. The
final FSFI score was then calculated by adding all the scores
for each domain and this ranged between 2 and 36.
Female sexual dysfunction was measured on a categorical
binary scale where any woman with a total score of less than
26.55 is considered to have sexual dysfunction and higher
scores are indicative of better sexual function (without FSD).
This tool was developed and validated by Rosen, and its
reliability was calculated using Cronbach’s alpha for internal
reliability and multivariate analysis of variance, dysfunction
diagnosis x FSFI domain with Bonferroni-corrected post hoc
comparisons to be 0.82.
Independent associations of the explanatory factors with
the outcome variable were assessed using chi-square test of
association, and the variables with a p < 0.25 were used in
the multivariate analysis. Factors associated with FSD were
determined using binary logistic regression adjusting for
the influence of the variables on each other or any possible
confounding factor.

Ethical considerations
The study commenced after ethical approval from the Aga
Khan University ethics review committee’s consideration.
Informed consent was obtained prior to recruiting
participants into the study, and it was made clear that
participants will be free of coercion, inducement or
intimidation. Participants in the study did not receive any
reward. However, declining to participate in the study did
not interfere with the patients’ intention of attending the
respective clinic.

Results
A total number of 596 participants were recruited from
three clinics: gynaecology outpatient clinic, family medicine
clinic and family planning clinic over the study duration
of February to April 2018. They submitted completed
questionnaires of which 30 (5%) were excluded because of
incomplete data. Data from 566 participants were included
in the analysis after checking for data completeness and
confirmation of informed consent and eligibility criteria. The
mean age of the participants was 32 years with an age range
of 18–49 years, whereas the mean age of their partners was
Open Access
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not much higher at 36 years. Most of the participants were
married (67%), and the majority had attained tertiary
education (82%). A large majority (98%) were African. Sixtytwo per cent had salaried employment. Only 13% had a
chronic illness and 10% were on chronic medication. Most
(67%) of the women were multiparous and 9% of the
participants had had at least one miscarriage. Christians
comprised the majority (97%) and 30% of women used
alcohol of which 9% used it within recommended limits of
two units a day and 21% used alcohol in excess of the
recommended amount for women. A minority (6%) of them
were active smokers. This has been elaborated in Table 1.
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TABLE 1: Sociodemographic characteristics of the study participants.
Social and/or demographic characteristics domain
All study participants

n

%

566

100.0

32.3

-

36

-

Age of subjects (years)
Mean age
Age of partners (years)
Mean age
Level of education
Primary education

9

1.6

Secondary education

93

16.4

Tertiary education

464

82.0

Single

116

20.5

Married

381

67.3

Contraceptive use and female sexual dysfunction

Separated

9

1.6

Divorced

5

0.9

Majority of the participants were using non-hormonal
contraception (58.5%), mainly male and female condoms
(21%), natural methods (17%) and the intrauterine device
(Copper T) (12.%). The rest (41.5%) were using hormonal
methods, including oral contraceptive pills (13.7%), implants
(12.4%) and levonorgestrel-releasing intrauterine system
(6.9%), as shown in Figure 1.

Other†

55

9.7

We used the defined cut-off score of 26.55 points to determine
the participants who had sexual dysfunction. The overall
prevalence of FSD was 38.7% (219 of the 566 participants) in
this study population. The hormonal contraceptive users
had a prevalence rate of 51.5%, while the non-hormonal
contraceptive users had a prevalence rate of 29.6%, which
was a significant difference. The prevalence of FSD for
each of the contraception types is presented in Table 2. The
prevalence was highest in implant users (63%), followed by
those on oral contraceptive pill (57%).
We examined the association between the various social and
demographic factors among all women in the study group
(Table 3).
The sociodemographic factors found to be significant
(variables with a p < 0.25) were used in the multivariate
analysis, described as Model I in Table 4. The factors
associated were then assessed using binary logistic
regression adjusting for marital status, level of education
and age of self, as described in Model II in Table 4. These
factors were assessed even though they did not meet the
cut-off significance value, as they are possible confounding
factors and because other studies had shown their
significance in association with FSD. There was collinearity
between alcohol intake and alcohol use; therefore, alcohol
use was fit in the multivariate model instead of alcohol
intake. We grouped marital status into single, married and
others (merged separated, divorced and other), and religion
was categorised as Christians and others (Islam, no religion,
other religions) in the regression analysis.
The factor that was found to have a significant association
with FSD was the use of hormonal contraception, which
had an adjusted odds ratio of 2.695 (1.869–3.886, p < 0.0001).
http://www.phcfm.org

Relationship status

Race
African

557

98.0

Asian

6

1.1

Other‡

3

0.5

Salaried employment

355

62.7

Self-employed

137

24.2

Unemployed

74

13.1

Present

73

12.9

Absent

493

87.1

Employment status

Chronic illness

Use of chronic medication
Present

55

9.7

Absent

511

90.3

Nulliparous

188

33.2

Multiparous

378

66.8

Previous pregnancies

Miscarriages
Yes

53

9.4

No

513

90.6

Religion
Christian

549

97

Islam

10

1.8

None

6

1.1

Other§

1

0.2

Yes

170

30.0

No

396

70.0

Within recommended limits

48

8.5

Excess of recommended limits

122

22.0

Alcohol use

Smoking status
Yes

33

5.8

No

533

94.2

Yes

235

41.5

No

331

58.5

Use of hormonal contraception

†, Others in ‘relationship status’ included ‘engaged’, ‘in a relationship’, ‘dating’, ‘good friends’,
‘couple’, ‘co-habiting’.
‡, Others in ‘race’ included ‘Arab’, ‘African-American’, ‘mixed-race people’.
§, Other in ‘religion’ included ‘atheist’.

Other factor associations that were found not to be significant
included self-employment, adjusted odds ratio of 1.362
(0.883–2.102, p < 0.163); unemployment, adjusted odds
ratio of 1.247 (0.696–2.234, p < 0.459); alcohol intake
(excess of recommended limits), adjusted odds ratio of 0.582
Open Access
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Male and female condoms

21.0

Natural methods

17.1

Oral contracepves

Type of contracep on

% of women

13.0

Implants

12.4

Non-hormonal coil

12.0

Hormonal coil

6.0

Injecble

6.0

Tubal ligaon or vasectomy

5.5

Transdermal patches

4.2

Lactaonal amenorrhoea method

1.2

Vaginal rings

0.2

Vaginal douching

0.2

spermicides

0.2
0

5

10

15

20

25

Percentage of women who were using the
type of contracep on
FIGURE 1: Frequency of use of contraceptive methods by the study participants.
TABLE 2: Contraceptive use and prevalence of female sexual dysfunction.
n with
FSD

Total
eligible

Prevalence
of FSD (%)

All study participants

219

566

38.7

Participants on hormonal contraceptives

121

235

51.5

Implants

44

70

62.9

Oral contraceptive pill

42

74

56.8

Injectable

16

34

47.1

Hormonal coil

15

39

38.5

Transdermal patches

7

24

29.2

Vaginal rings

1

1

100.0

Participants on non-hormonal contraceptives

98

331

29.6

Male and female condoms

42

119

35.3

Natural methods

42

97

35.3

Non-hormonal coil

19

68

27.9

Tubal ligation

8

31

25.8

Vaginal douching

0

1

0.0

Spermicides

0

1

0.0

Variable

FSD, female sexual dysfunction.

(0.279–1.212, p < 0.148); having a history of miscarriage(s),
adjusted odds ratio of 0.613 (0.311–1.211, p < 0.159); having
a chronic illness, adjusted odds ratio of 0.769 (0.300–1.971,
p < 0.585); and the use of chronic medication, adjusted odds
ratio of 0.77 (0.258–2.1, p < 0.59).
The above-named factors showed a trend towards significant
association with FSD, as described in Model I of Table 4, but
the study was not powered enough to show this association.

Discussion
The present study showed that the overall prevalence of
FSD in women in the study group was 38%. In comparison,
the prevalence of FSD has been reported to be much higher,
as high as 72.8%, in a Ghanaian prospective cross-sectional
survey by Amidu et al. and 63% in a Nigerian crosssectional study by Fajewonyomi et al. even with the study
populations having had many similar sociodemographic
characteristics.7,8
http://www.phcfm.org

The prevalence of FSD in the women using hormonal
contraception was 51.5%, compared to 29.6% among those
using non-hormonal contraception, which was noted to be
significantly different. On the same note, Wallwiener et al.
reported that 36.7% of subjects using oral hormonal
contraceptives and 31.3% of subjects using non-oral
hormonal contraceptives were found to have FSD as
compared to 27.4% of subjects using non-hormonal
contraceptives.9 Although there exists contrary evidence
that hormonal contraception has shown to increase positive
indicators of sexual functioning as seen in a prospective
study conducted by Guida et al.10 in Italy, and in a similar
study conducted by Higgins et al.11 that showed more
positive method-related changes in women using hormonal
contraception, there is not much evidence of the effect of the
scores of sexual functioning and comparator prevalence
studies of FSD in the two groups described. In the present
study, the use of hormonal contraception and the difference
in the prevalence of FSD in the two groups were noted to be
statistically significant.10,11
Alcohol intake was not found to have an effect on FSD in
women who took alcohol within and in excess of the
recommended limits. This may be attributed the fact that only
30% of the study sample took alcohol at all. In comparison to
this, in a study conducted in Ghana by Amidu et al., alcohol
intake was the only significant risk factor associated with
FSD. This may be attributed to the physiological effects
of alcohol on the female genitalia and the psychological
phenomena of ‘alcohol myopia’ and ‘alcohol expectancy’.
These are cognitive–physiological theories that are explained
as a consequence of alcohol’s narrowing of perceptual and
cognitive functioning. This can affect the expressions and
emotions of women, and are associated with thoughts of
pleasure, sexual performance or distress.7
History of miscarriage(s) was also not found to have a
significant association with FSD in our study. This is contrary
Open Access
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TABLE 3: Prevalence of female sexual dysfunction across different categories of sociodemographic factors.
Variables

Frequency/mean

Percent/s.d.

p

FSD
Absence (n = 347)

Present (n = 219)

n

%

n

%

32.3

7.1

32.5

7.0

32.0

7.4

0.454

36

7.8

36.2

7.8

35.7

8.0

0.502

Single

116

20.5

67

57.8

49

42.2

0.296

Married

381

67.3

244

64.0

137

36.0

Separated

9

1.6

4

44.4

5

55.6

Divorced

5

0.9

2

40.0

3

60.0

Other

55

9.7

30

54.6

25

45.4

9

1.6

6

66.7

3

33.3

Secondary

93

16.4

56

60.2

37

39.8

Tertiary

464

82.0

285

61.4

179

38.6

557

98.4

342

61.4

215

38.6

Asian

6

1.1

3

50.0

3

50.0

Others

3

0.5

2

66.7

1

33.3

Salaried employment

355

62.7

227

63.9

128

36.1

Self-employment

137

24.2

77

56.2

60

43.8

Unemployed

74

13.1

43

58.1

31

41.9

Yes

235

41.5

114

48.5

121

51.5

No

331

58.5

233

70.4

98

29.6

Yes

73

12.9

52

71.2

21

28.8

No

493

87.1

295

59.8

198

40.2

Yes

55

9.7

40

72.7

15

27.3

No

511

90.3

307

60.1

204

39.9

Christian

549

97

335

61.0

214

39.0

Muslim

10

1.8

7

70.0

3

30.0

None

6

1.1

4

66.7

2

33.3

Other

1

0.2

1

100.0

0

0.0

Yes

170

30.2

114

66.7

57

33.3

No

395

69.8

233

59.0

162

41.0

Yes

33

5.8

20

60.6

13

39.4

No

533

94.2

327

61.4

206

38.6

Within limits

48

8.5

28

58.3

20

41.7

None

396

70.0

234

59.1

162

40.9

Excessive

122

21.6

85

69.7

37

30.3

Nulliparous

188

33.2

114

60.6

74

36.4

Multiparous

378

66.8

233

61.6

145

38.4

No

513

90.6

308

60.0

205

40.0

Yes

53

9.4

39

73.6

14

26.4

Age of participants (mean)
Age of partner (mean)
Marital status (frequency)

0.924

Level of education
Primary

0.835

Race
African

0.239

Employment status

< 0.0001

Use of hormonal method

0.062

Presence of chronic illness

0.067

Use of chronic medication

0.791

Religion

0.085

Alcohol intake

0.932

Smoking status

0.100

Alcohol use

0.818

Parity

0.054

Miscarriage

FSD, female sexual dysfunction.

to findings of Shreffler et al. in 2011 who discussed how loss of
pregnancy had a lasting effect of emotions of guilt or distress
that had strong psychological implications, which could
eventually lead to a significant effect on sexual function.12
There was no significant association of having a chronic
illness and the use of chronic medication with FSD in
http://www.phcfm.org

our study. This is contrary to most studies that show a
consistent proportional negative effect of chronic disease on
sexual function. Many chronic illnesses, such as diabetes,
HIV and rheumatoid arthritis, exert unwanted effects via
pathophysiological mechanisms, eventually reducing sexual
satisfaction scores in the women. The most common chronic
illness present in our study population was hypertension.
Open Access
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TABLE 4: Parameter estimates of the factors associated with female sexual dysfunction.
Variables

Model I
OR

95% CI

Model II
p

OR

95% CI

p

Marital status
Single

-

-

-

-

-

-

Married

0.768

0.503–1.173

0.221

0.554

0.333–0.922

0.023

Other†

1.253

0.688–2.282

0.460

1.235

0.658–2.320

0.511

Level of education
Primary

-

-

-

-

-

-

Secondary

1.321

0.311–5.615

0.706

0.941

0.199–4.442

0.938

Tertiary

1.256

0.310–5.086

0.749

1.086

0.241–4.895

0.914

Race
African

-

-

-

-

-

-

Asian

1.591

0.318–7.952

0.572

-

-

-

Others

0.795

0.072–8.824

0.852

-

-

-

Employment status
Salaried employment

-

-

-

-

-

-

Self-employment

1.382

0.925–2.063

0.114

1.362

0.883–2.102

0.163

Unemployed

1.278

0.768–2.129

0.345

1.247

0.696–2.234

0.459

Yes

2.524

1.782–3.574

< 0.0001

2.695

1.869–3.886

< 0.0001

No

-

-

-

-

-

-

Yes

0.602

0.351–1.030

0.064

0.769

0.300–1.971

0.585

No

-

-

-

-

-

-

Yes

0.564

0.304–1.048

0.07

0.77

0.258–2.296

0.639

No

-

-

-

-

-

-

Use of hormonal method

Presence of chronic illness

Use of chronic medication

Religion
Christian

-

-

-

-

-

-

0.652

0.226–1.877

0.428

-

-

-

Yes

1.032

0.52–2.119

0.932

-

-

-

No

-

-

-

-

-

-

Age of participants

0.991

0.968–1.015

0.454

1.01

0.979–1.040

0.561

Age of partner

0.993

0.971–1.014

0.502

-

-

-

Other‡
Smoking status

Alcohol use
Within limits

-

-

-

-

-

-

None

0.969

0.528–1.780

0.92

0.977

0.510–1.871

0.943

Excessive

0.609

0.305–1.217

0.16

0.582

0.279–1.212

0.148

Parity
Nulliparous

-

-

-

-

-

-

Multiparous

0.959

0.670–1.372

0.818

-

-

-

Miscarriage
No

-

-

-

-

-

-

Yes

0.539

0.286–1.018

0.057

0.613

0.311–1.211

0.159

FSD, female sexual dysfunction; CI, confidence interval; OR, odds ratio.
†, Others in ‘relationship status’ included ‘engaged’, ‘in a relationship’, ‘dating’, ‘good friends’, ‘couple’, ‘co-habiting’.
‡, Others in religion’ included ‘atheist’.

As explained above, only a small percentage (12.9%) of
women in our study population had any chronic illness, had
a young median age (32 years) and only 9.7% used any
chronic medication; therefore, our findings are contrary to
those of Doumas et al. in 2006 that showed a significant
association of having hypertension with FSD in a larger
study of sexually active, hypertensive women.13
The present study also showed that being self-employed or
unemployed did not have a significant effect on sexual
dysfunction. This was in comparison to the association of
employment status and FSD that has been shown in many
http://www.phcfm.org

different studies conducted in different parts of the world.
This is attributed to the assumption that women who are
more financially stable are likely to have higher levels of
confidence and self-esteem, contributing to higher sexual
satisfaction scores than unemployed women. Employed
women also tend to have better interpersonal skills that are
associated with better desire and more willingness to have
sexual activity.14
There was no significant effect of smoking on FSD in our
study population, which is contrary to findings reported in
other studies that have shown stronger associations. This is
Open Access
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related to mechanisms of the negative effects of nicotine on
the vascular system, reducing genital blood flow by inhibiting
vasoactive substances such as endothelial relaxing factor and
nitric oxide. This association was not seen in the present
study, which is most likely because of the small number
(5.8%) of active smokers in the population compared to larger
populations of smokers in Europe and the United States.
The study participants were noted to be a generally young
population with small age gaps with their partners. A large
number were non-smokers and did not take alcohol, and was
reflected as very few of them having chronic illnesses and
fewer of them using any chronic medications. Majority of
them shared characteristics such as being married, having a
tertiary education and being employed. An expected finding
was that most women belonged to the African race, were
Christians and had had more than one pregnancy.14
It was noted in the present study that more participants
were using non-hormonal methods of contraception than
hormonal methods, mainly male and female condoms, and
natural methods. In the group of hormonal contraception
users, most were using oral contraceptives and implants.
This is contrary to the report of the Kenya Demographic and
Health Survey, which stated a higher prevalence of hormonal
contraception with majority using injectable methods.4
Increasing age of participants and higher ages of their
partners have shown to have a significant negative effect on
sexual dysfunction as seen in other studies, but this did not
reflect in our findings; however, it could be largely because of
a younger mean age of participants in the present study and
smaller age gaps with their partners as seen in the present
study population.14
The present study did not find a significant association
between the level of education and FSD. This association has
not been clearly defined in the literature as well as with some
studies showing an inverse effect of the years of education
and prevalence of FSD such as the cross-sectional study
conducted in Nigeria by Fajewonyomi et al. Other larger
studies still report a proportionate effect on FSD. The
association may not have come out very clear in the present
study population as majority of the participants had attained
tertiary level of education – there were very few with lower
levels of education.14
The limitations of this study were that the findings may not
be generalisable to the entire population of Kenya as it was
conducted in a tertiary hospital, in the private health care
clinical setting, with majority of the participants having
high education levels, more financial security and health
insurance, and higher employment levels. This also limited
the ability of the study to elaborate on other associations
that were close to significant in the study sample such as
employment, education levels and religion. Also, stratification
of the different types of FSD was not done as part of the data
analysis in this study.
http://www.phcfm.org

Original Research

Further research to build on womens’ sexual health and
sexual function should be conducted in more centres
including rural settings in Kenya after adequate translation
and validation of FSFI questionnaire to Kiswahili and in
populations where some of the expected associations can be
better evaluated and to build on this knowledge by further
elaborating the association of each individual type of
hormonal contraception with FSD.

Conclusion
The present study found a high prevalence of FSD in the
study population. The most common methods of contraception
were the use of male and female condoms and natural
methods followed by the use of oral contraceptives and
implants. We noted a strong association of FSD with the use
of hormonal contraception. Other factors were found to have
close to significant association with FSD, but this study
was not adequately powered to show this association. These
factors included self-employment and unemployment, use of
alcohol within and in excess of the recommended limits and
a history of miscarriages; the presence of any chronic illness
or use of any chronic medication showed less significant
associations with FSD.
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